Antipyretic effect of paracetamol vs mefenamic acid in treatment of febrile childre

Phase 4

• Conditions: Health Condition 1: R508- Other specified fever

• Registration Number: CTRI/2018/12/016798
• Lead Sponsor: Dr Amruta Loya

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Children between 6 months and 5years of age, of either sex and with a Axillary temperature of 38°C/100.4 F or above included in the study

Exclusion Criteria

If patient received any antipyretic drug in previous 6 hrs

History of hypersensitivity to study medication

patients receiving antibiotics

Patients admitted in ICU

Patients with active gastrointestinal bleeding

Known coagulopathy

Chronic renal, liver and cardiac failure

Pt medicated with warfarin, heparin or any other anti hypertensives

Any medication that could interfere with the study was not permitted during the study.

Any clinical adverse event, serious illness or other medical condition in view of investigator/treating doctor, in which continued participation was not in the best interest of the subject

Voluntary decision of legal guardian/patient to withdraw from the study

Any patient who required the use of an unacceptable concomitant medication or intervention that interfered with the study

If febrile seizure/convulsions occurred to the child during the study.

If the patients temp does not drop to normal range , then patient will be excluded from the study

If body temp increases above 104 degree farenheit or decreases below 96.5 degree farenheit.

Study & Design

• Study Type: Interventional
• Study Design: Not specified